Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003

Cancer

Volumn 113, Issue 10 SUPPL., 2008, Pages 2901-2909

  Ryerson, A Blythe ^a   Peters, Edward S ^b   Coughlin, Steven S ^a   Chen, Vivien W ^b   Gillison, Maura L ^c   Reichman, Marsha E ^d   Wu, Xiaocheng ^b   Chaturvedi, Anil K ^d   Kawaoka, Kelly ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Human papillomavirus; Oral cancer; Oropharyngeal cancer

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER INCIDENCE; CHILD; DISEASE ASSOCIATION; FEMALE; HISPANIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PAPILLOMA VIRUS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TONGUE CANCER; TONSIL CANCER; UNITED STATES; VIRUS CARCINOGENESIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS;

EID: 56449085411     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23745     Document Type: Article

References (50)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer Clin. 2007;57:43-66.
2. U.S. Cancer Statistics Working Group. U.S. cancer statistics: 2004 incidence and mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2007.
3. Dobrossy L. Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev. 2005;24:9-17.
4. Stambuk HE, Karimi S, Lee N, Patel SG. Oral cavity and oropharynx tumors. Radiol Clin North Am. 2007;45:1-20.
5. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287.
6. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst. 1993;85:465-473.
7. Furniss CS, McClean MD, Smith JF, et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer. 2007;120:2386-2392.
8. Mashberg A, Boffetta P, Winkelman R, Garfinkel L. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer. 1993;72:1369-1375.
9. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol. 2001;13:176-182.
10. Wiseman SM, Swede H, Stoler DL, et al. Squamous cell carcinoma of the head and neck in nonsmokers and nondrinkers: an analysis of clinicopatholgic characteristics and treatment outcomes. Ann Surg Oncol. 2003;10:551-557.
11. Dahlstrand H, Dahlgren L, Lindquist D, Munck-Wikland E, Dalianis T. Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res. 2004;24:1829-1835.
12. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003;27:1463-1470.
13. Franceschi S, Munoz N, Bosch XF, Snijders PJ, Walboomers JM. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev. 1996;5:567-575.
14. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31:744-754.
15. Herrero R, Castellsague X, Pawlita M, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-1783.
16. Klussmann JP, Weissenborn SJ, Wieland U, et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol (Berl). 2003;192:129-132.
17. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998;20:250-265.
18. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125-1231.
19. Ringstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res. 2002;8:3187-3192.
20. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope. 1998;108:1098-1103.
21. Tran N, Rose BR, O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck. 2007;29:64-70.
22. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res. 2004;23:561-566.
23. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
24. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467-475.
25. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32(suppl 1):S59-S66.
26. Chang F, Syrjanen S, Kellokoski J, Syrjanen K. Human papillomavirus (HPV) infections and their associations with oral disease. J Oral Pathol Med. 1991;20:305-317.
27. Furrer VE, Benitez MB, Furnes M, Lanfranchi HE, Modesti NM. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions. J Oral Pathol Med. 2006;35:338-344.
28. Miller CS. Herpes simplex virus and human papillomavirus infections of the oral cavity. Semin Dermatol. 1994;13:108-117.
29. Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96:449-455.
30. Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31:259-266.
31. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004;57:449-455.
32. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
33. Bradford CR, Zacks SE, Androphy EJ, Gregoire L, Lancaster WD, Carey TE. Human papillomavirus DNA sequences in cell lines derived from head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg. 1991;104:303-310.
34. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg. 1997;123:513-516.
35. Ishibashi T, Matsushima S, Tsunokawa Y, et al. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1990;116:294-298.
36. Watson M, Saraiya M, Ahmed F, et al. Using population-based cancer registry data to assess the burden of HPV-associated cancers in the US: overview of methods. Cancer. 2008;113(10 suppl):2841-2854.
37. Surveillance Research Program. National Cancer Institute SEER-Stat Software, Version 6.1.4. Bethesda, MD: National Cancer Institute; 2005.
38. Surveillance, Epidemiology, and End Results Program. Summary staging guide for the Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD: National Institutes of Health, National Cancer Institute; 1977
39. Surveillance, Epidemiology, and End Results Program. Summary staging manual 2000. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2005.
40. Howe HL, Jamison PM, Havener L, Chen VW, Ries LAG. Site-specific comparison of summary stage 1977 and summary stage 2000 coding. Available from URL: http://www.naaccr.org/index.asp?Col_SectionKey511&Col_ContentID5397. Accessed on July 11, 2008.
41. Phillips JL, ed. Summary stage: data effects of the changes in 2000. Available from URL: http://www.naaccr.org/filesystem/pdf/ Summary%20Stage%20Report%201-21-04b.pdf. Accessed on July 11, 2008.
42. Department of Health and Human Services. Tobacco use among U.S. racial/ethnic minority groups-African-Americans, American-Indians and Alaska Natives, Asian-Americans and Pacific Islanders, and Hispanics: a report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 1998.
43. Greenberg RS, Haber MJ, Clark WS, et al. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology. 1991;2:194-200.
44. Kabat GC, Chang CJ, Wynder EL. The role of tobacco, alcohol use, and body mass index in oral and pharyngeal cancer. Int J Epidemiol. 1994;23:1137-1144.
45. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the U.S. J Clin Oncol. 2008;26:612-618.
46. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005;103:1843-1849.
47. Davies L, Welch HG. Epidemiology of head and neck cancer in the U.S. Otolaryngol Head Neck Surg. 2006;135:451-457.
48. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:1429-1435.
49. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S11-S25.
50. Mellin H, Dahlgren L, Munck-Wikland E, et al. Human papillomavirus type 16 is episomal, and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer. 2002;102:152-158.